News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Publicis to buy LiveRamp for $2.17B to boost agentic AI and raises medium-term growth targets.
  • Life360 board authorized up to $225M multi-year share repurchase to offset stock-compensation dilution.
  • Supreme Court allows state negligent-selection suits against freight brokers, raising liability risk for brokers.
  • Two Navy E/A-18G Growlers collided near Mountain Home; four crew ejected safely and base locked down pending investigation.
  • Bernstein classifies US data center markets, emphasizing major metro hubs as strategic and resilient for public operators.
  • Moscow market closed mixed as MOEX Russia Index finished unchanged, with miners and retailers lagging and financials leading.
  • Design Therapeutics schedules May 18 webcast to release Phase 1/2 RESTORE-FA data for DT-216P2 targeting Friedreich's ataxia.

Latest Articles

Newmont Executive Sells $164,381 in Stock as Firm Faces Mixed Analyst Views

Newmont Executive Sells $164,381 in Stock as Firm Faces Mixed Analyst Views

Mark C. Rodgers, MD, Newmont’s Africa-Asia Pacific executive, sold 1,361 shares on March 3, 2026 for $120.78 each, netting $164,381. The transaction occurred under a Rule 10b5-1 plan and follows a 176% year-over-year rally in Newmont shares. Analysts’ views vary from bullish upgrades to cautious targets as the company navigates production declines,…

Bank Negara Malaysia Keeps Benchmark Rate at 2.75% as Inflation Remains Muted

Bank Negara Malaysia Keeps Benchmark Rate at 2.75% as Inflation Remains Muted

Bank Negara Malaysia held its overnight policy rate at 2.75% on Thursday, in line with the unanimous forecast of 27 economists surveyed by LSEG. The central bank's choice reflects subdued headline inflation of 1.6% year-over-year in January and a view that current price dynamics are not an immediate policy concern, even as global energy prices rise…

Boskalis posts record 2025 EBITDA but flags weaker 2026 outlook

Boskalis posts record 2025 EBITDA but flags weaker 2026 outlook

Boskalis reported a record €1,336 million in EBITDA for fiscal year 2025, a 3% rise year-on-year and a 16% increase when excluding a prior exceptional gain. Revenue grew 2%, driven by Offshore Energy and a sharp improvement in Towage that offset a decline in Dredging & Infra. The company cautioned it does not expect to match the 2025 performance in…

Hunting Keeps 2026 Targets Intact as Order Book Shrinks

Hunting Keeps 2026 Targets Intact as Order Book Shrinks

Hunting PLC delivered fiscal 2025 results aligned with prior guidance, including EBITDA that matched expectations, while revealing a marked reduction in its order book. Management kept fiscal 2026 EBITDA guidance unchanged, approved a fresh $40 million share buyback and outlined additional cost cuts even as certain divisional margins softened.

Babcock Posts Small Earnings Beat and Unveils £75 Million Buyback

Babcock Posts Small Earnings Beat and Unveils £75 Million Buyback

Babcock International reported fiscal 2025 results that modestly outperformed consensus on earnings per share and adjusted EBITA, while matching revenue expectations. The defence-focused engineering group recorded stronger-than-expected free cash flow, expanded its order book and announced a £75 million share buyback that prompted an update to year…

Cicor posts sales above estimates as acquisitions weigh on margins

Cicor posts sales above estimates as acquisitions weigh on margins

Cicor Technologies reported fiscal 2025 revenue of CHF617m, slightly above analyst projections, but showed margin compression linked to recent acquisitions. Orders and free cash flow outperformed estimates, while the company set sales and EBITDA guidance for fiscal 2026 that anticipates a return to organic growth later in the year.

Honest Company's Chief Innovation Officer Sells 73,685 Shares; Stock, Guidance and Analyst Takeaways Noted

Honest Company's Chief Innovation Officer Sells 73,685 Shares; Stock, Guidance and Analyst Takeaways Noted

Honest Company Chief Innovation Officer Stephen Winchell reported the sale of 73,685 shares on March 3, 2026, per a Form 4 filing. The transaction totaled $209,265 at a weighted average price of $2.84. After the sale Winchell directly holds 517,466 shares, including 444,422 restricted stock units. The stock has traded up to $2.93 recently. The comp…

Verisign General Counsel Sells 498 Shares, Realized $115,426

Verisign General Counsel Sells 498 Shares, Realized $115,426

Verisign Executive Vice President, General Counsel and Secretary Thomas C. Indelicarto sold 498 shares of Verisign stock on March 3, 2026, across two trades that generated $115,426. The filing records his post-sale holdings and recent dividend-equivalent restricted stock units; the company reported mixed fourth-quarter 2025 results and trades at a …

Editas Medicine CFO Sells Small Stake to Cover RSU Tax Bill

Editas Medicine CFO Sells Small Stake to Cover RSU Tax Bill

Amy Parison, senior vice president and chief financial officer of Editas Medicine, sold 474 shares of the company’s common stock on March 3, 2026, under a pre-arranged automatic sales plan established in 2022 to meet tax obligations arising from restricted stock units that vested on March 2, 2026. The trade, reported on a Form 4 filing, totaled $95…

Oklo Co-Founder Caroline Cochran Disposes $12.66 Million in Shares

Oklo Co-Founder Caroline Cochran Disposes $12.66 Million in Shares

Caroline Cochran, co-founder and chief operating officer of Oklo Inc. (OKLO), sold Class A common shares on March 2, 2026, in transactions totaling $12,658,097. The sales were carried out under a Rule 10b5-1 trading plan adopted March 31, 2025. The moves come amid significant corporate developments for Oklo, including a binding agreement with Meta …

Editas Medicine Executive Sells 749 Shares to Cover RSU Taxes

Editas Medicine Executive Sells 749 Shares to Cover RSU Taxes

Editas Medicine Executive Vice President and Chief Scientific Officer Linda Burkly sold 749 shares on March 3, 2026, under a pre-established automatic sales instruction plan to satisfy tax withholding tied to restricted stock unit vesting. The disposal generated roughly $1,512. The sale was not a discretionary trade, and Burkly retains a direct sta…